Newsroom (42)
News
02/11/2021
Wading deeper into target discovery and validation, Immunai bags $60M to beef up both AI algorithms and lab benches
News
02/11/2021
Biotech firm Immunai raises $60 million in private funding round
News
02/11/2021
Immunai Gets Series A Funding for Genomics Database Advancements
News
02/11/2021
Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too
News
02/11/2021
Better Disease Treatments: Immunai Inks $60M Series A To Fuel Immune System Data Set
Press Releases
02/11/2021
Immunai Raises $60M to Reprogram Immunity – the funding will fuel the growth of Immunai’s proprietary AI-first single-cell drug discovery platform
Publications
02/11/2021
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors
News
10/21/2020